Healthcare Businesses for Sale and Investment in Oceania

Our groundbreaking recombinant formulation induces stem cell recruitment and differentiation, stimulating intervertebral disc cell matrix for regeneration and self-healing. - Developed as an image-guided intra-disc administration under local anesthesia, ensuring precision and effectiveness in the therapeutic process. - A therapeutic candidate for the regeneration of spinal intervertebral discs in patients with debilitating degenerative disc conditions. - Induces the mobilization and differentiation of stem cells, leading to de novo regeneration of intervertebral discs and stabilization of the affected spine. - Backed by a compelling biological rationale and a robust preclinical data set, demonstrating a strong proof of concept. - Cure back pain with personalized, targeted, regenerative therapy via a non-invasive injection directly into the disc. - Offers a cost-effective and quick procedure, aiming to enhance the quality of life for patients. - Positioned in the $300 billion back pain industry, addressing a significant market need. - Great investment opportunity at the seed stage, with RDTI registration in Australia reflecting a commitment to research and development. - Administered as a convenient day procedure service, either in a radiology suite or a day procedure facility. - Founded by individuals with decades of experience in the industry.

Our groundbreaking recombinant formulation induces stem cell recruitment and differentiation, stimulating intervertebral disc cell matrix for regeneration and self-healing. - Developed as an image-guided intra-disc administration under local anesthesia, ensuring precision and effectiveness in the therapeutic process. - A therapeutic candidate for the regeneration of spinal intervertebral discs in patients with debilitating degenerative disc conditions. - Induces the mobilization and differentiation of stem cells, leading to de novo regeneration of intervertebral discs and stabilization of the affected spine. - Backed by a compelling biological rationale and a robust preclinical data set, demonstrating a strong proof of concept. - Cure back pain with personalized, targeted, regenerative therapy via a non-invasive injection directly into the disc. - Offers a cost-effective and quick procedure, aiming to enhance the quality of life for patients. - Positioned in the $300 billion back pain industry, addressing a significant market need. - Great investment opportunity at the seed stage, with RDTI registration in Australia reflecting a commitment to research and development. - Administered as a convenient day procedure service, either in a radiology suite or a day procedure facility. - Founded by individuals with decades of experience in the industry.

New Zealand based company in the process to start a 5-star luxury cruise ship based long-term old age care residence. - The facility will have a global international customer base of over 550 elderly HNWI, VHNWI, and UHNWI full-time residents per ship. - Business has burgeoning growth rate projections, scaleable and global from day one. The niche market is untapped and to secure first-to-market advantages with economic and physical moats for the next 2-7 years. - Several strategic partner MOUs already in place, with the necessary industry business expertise on the board of advisors to ensure the success of the business model. - We will have a bespoke high-end brand which includes beauty salons and multiple life-enhancing programs for our residents. - We have already finalized the ship we wish to buy and waiting for the investment. - Company does not have any liability. - Business is 100% owned by 2 directors who are husband and wife. - Promoter has over 10 years of experience in this field. - Our residence will have a refundable accommodation deposit per luxury stateroom is currently at USD 65,000 per sqm, and the daily rate per resident will be USD 550 per day for services, and an a la carte menu for luxury items, additional medical and hospitality services,

We are a startup disability service provider based in Sydney NSW. - We provide nursing homes to people who have disabilities. - The business is currently operating a center in Australia and is in the process of starting a center in Dubai. - Currently, catering to 10 patients which is the full capacity. - Have an in-house team of caregivers with expertise in the field. - The founders saw there was a need in the market for a luxury disability accommodation facility and high-end quality care. This is when the business was formed and company policies and procedures were designed to implement the highest quality of care given to our clients. - We strive to deliver the best care in the industry, client safety and satisfaction are our number one priority. - Our management team ensures care is been given to the highest standards, ensuring compliance with the strict guidelines in the company policies are been followed. - Dubai center is a wholly-owned subsidiary of the Australian parent company. - Revenue generation is done through government funding in Australia and fees from the admitted patients. - Business is debt-free and is managed by 2 partners having equal shares. - Parent company generates an average monthly sales of AED 260 thousand and had sales of AED 3.1 million last year with an EBITDA margin of 35% - One partner is located in Dubai while the other is in Australia.

We are a medical procurement and distribution company. - Some of our clients include Port Moresby General Hospital and Buka General Hospital. - We procure products from various reputed companies such as Vestfrost Solutions, Elastec and Chengdu Seamaty Technology. - Products in our portfolio include pH meters, oxygen cylinders, blood bags, diagnostic tests, various monitors and dental instruments. - Managing Director is a medical doctor with over 20 years of experience and contacts within the pharma industry.